Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Becker-type muscular dystrophy.

W G Bradley, M Z Jones, J M Mussini

    Muscle & Nerve
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Becker-type muscular dystrophy is a slowly progressive X-linked condition. Muscle biopsies reveal features of both myopathy and denervation, distinct from Duchenne muscular dystrophy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey.

    The British journal of dermatology·2014
    Same author

    Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

    Mucosal immunology·2014
    Same author

    Marked systemic amyloid angiopathy in patients with val 107 transthyretin mutation.

    Journal of clinical neuromuscular disease·2008
    Same author

    [Deafness, diabetes and cancer: chance association or etiological link?].

    La Revue de medecine interne·2005
    Same author

    Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.

    HIV medicine·2001
    Same author

    A novel autosomal dominant distal myopathy with early respiratory failure: clinico-pathologic characteristics and exclusion of linkage to candidate genetic loci.

    Annals of neurology·2001
    Same journal

    Cytokine Profiles in Myasthenia Gravis Subgroups and the Lack of Any Effect of Immunosuppression.

    Muscle & nerve·2026
    Same journal

    Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts.

    Muscle & nerve·2026
    Same journal

    Presynaptic Congenital Myasthenic Syndromes.

    Muscle & nerve·2026
    Same journal

    AGRN-, LRP4-, MUSK-Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms.

    Muscle & nerve·2026
    Same journal

    The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic Mechanisms.

    Muscle & nerve·2026
    Same journal

    IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

    Muscle & nerve·2026
    See all related articles

    Area of Science:

    • Neurology
    • Genetics
    • Pathology

    Background:

    • Becker-type muscular dystrophy is a slowly progressive, X-linked myopathy.
    • Clinical, cardiologic, and electrophysiologic features are variable.
    • Pathologic findings can overlap with other neuromuscular diseases.

    Purpose of the Study:

    • To review clinical, cardiologic, electrophysiologic, and pathologic changes in Becker-type muscular dystrophy.
    • To differentiate Becker-type muscular dystrophy from Duchenne muscular dystrophy based on pathology.
    • To analyze serum creatine kinase levels in affected families.

    Main Methods:

    • Review of clinical data from eight families.
    • Electromyography (EMG) analysis.
    • Muscle biopsy interpretation.

    Related Experiment Videos

  • Serum creatine kinase level assessment.

    • Main Results:

    • Patients typically retained ambulation until age 16 and lived beyond 20 years.
    • EMG and muscle biopsy showed mixed myopathic and neurogenic features.
    • Common biopsy findings included fiber atrophy/hypertrophy, split fibers, pyknotic nuclei, necrosis, regeneration, and fibrosis.
    • Pathologic changes were distinct from Duchenne muscular dystrophy but shared features with other chronic neuromuscular disorders.

    Conclusions:

    • Becker-type muscular dystrophy presents with a unique combination of myopathic and neurogenic features on biopsy.
    • The slow progression and distinct pathological profile differentiate it from Duchenne muscular dystrophy.
    • Further research into the specific mechanisms and variations within Becker-type muscular dystrophy is warranted.